Krystal Biotech Inc — Balance Sheet (NASDAQ:KRYS) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Dividends

Quarterly Annual

Total assets 310.84 M626.29 M558.45 M818.36 M1.06 B1.33 B Total liabilities 18.76 M32.72 M36.22 M39.71 M109.46 M114.23 M Total equity 292.08 M593.58 M522.23 M778.64 M946.38 M1.22 B Total liabilities & shareholders' equities 310.84 M626.29 M558.45 M818.36 M1.06 B1.33 B Total debt —————— Net debt ——————

News

Krystal Biotech director Janney sells shares worth $10.1 million

Krystal Biotech (KRYS) director Rossi sells shares worth $4.95 million

AI Play SPX Leads 17 Top Performers Onto Best Stock Screens Like IBD 50, Stock Spotlight, More

Krystal Biotech Q4 Earnings Beat Estimates, Revenues Miss Mark

Dow Jones Futures Fall After Market Reverses Higher; Meta Deal Lifts Nvidia, Hits AI Rivals

Krystal Biotech, Inc. (KRYS) Q4 2025 Earnings Call Transcript

Krystal Biotech stock reaches all-time high at 296.78 USD

Krystal Biotech Q4 2025 slides: VYJUVEK drives revenue growth, pipeline advances

Krystal Biotech shares fall over 2% despite Q4 earnings, revenue beat

Krystal Biotech earnings beat by $0.12, revenue topped estimates

Krystal Biotech in the spotlight with earnings on deck Tuesday

Exact Sciences (EXAS) Reports Q4 Loss, Tops Revenue Estimates